ImmuNext, Inc.

Private

Lebanon, New HampshireHealthcare & Life Scienceshttps://immunext.com/

Last Round

Strategic

May 9, 2024

Total Funding Raised

$539.62M

Company Overview

ImmuNext, Inc. is a biotechnology company that develops immunomodulatory therapeutics for the treatment of cancer and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

drug discoveryimmunotherapybiotechpreclinical developmentimmunomodulatory therapeuticsantibody developmentcheckpoint inhibitorsdrug licensingVISTA therapeuticsCD40L antibodiesbiopharmaoncology pipelineautoimmune disease researchimmunometabolismasset licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ImmuNext, Inc. Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ImmuNext, Inc. Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Strategic	May 9, 2024

View all Funding Rounds

ImmuNext, Inc. Investors

Notable investors and investment history

Investor	Rounds
National Institute of Allergy and Infectious Diseases	Grant
NIH RADx	Grant
Royalty Pharma	Strategic

View all Investors

ImmuNext, Inc. Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ImmuNext, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ImmuNext, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersLebanon, New Hampshire

Employee Range3

Year Founded2011

Last FundingMay 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.